With more and more dispensaries turning to Altopa's innovative oil blending platform Oblend, the company has decided to pivot from B2C to B2B. Here to tell us about it is Nicole Wicker, CEO of Altopa. Learn more at https://www.oblend.com  Key Takeaways: Nicole's background and how she came to start Altopa An inside look at Altopa and its "portable dispensary device" Oblend How the Oblend creates CBD formulas for specific needs and preferences Why Altopa is transitioning from a consumer-focused to a business-focused company How Altopa partners with dispensaries looking to implement the Oblend Increasing demand for the Oblend among healthcare providers, formulators, and patients  Where Nicole sees Altopa heading in the next 3-5 years